NEW YORK CITY, NY / ACCESS Newswire / February 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...

Teva's stock is a speculative buy with potential upside if biosimilars succeed, but risks remain high due to debt and ...

Israeli drug manufacturer Teva Pharmaceutical Industries has resumed the deliveries of the scarce epilepsy drug Finlepsin ...

The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.

DelveInsight's High Potency Active Pharmaceutical Ingredients Market Insights report provides the current and forecast market ...

NORTHAMPTON, MA / / February 27, 2025 / In high-income countries, more than 80% of children diagnosed with cancer will survive. Yet in some low- and middle-income countries, this number ...

NORTHAMPTON, MA / ACCESS Newswire / February 27, 2025 / In high-income countries, more than 80% of children diagnosed with ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Breast cancer remains a significant health challenge globally with approximately 2.3M new cases in 2022. While breast cancer ...

Yes, we know, it's still February and yet we can't stop going on about hiking sandals, but what can we say? Our toes are ...